179 related articles for article (PubMed ID: 37725107)
1. Identifying the severity of diabetic retinopathy by visual function measures using both traditional statistical methods and interpretable machine learning: a cross-sectional study.
Wright DM; Chakravarthy U; Das R; Graham KW; Naskas TT; Perais J; Kee F; Peto T; Hogg RE
Diabetologia; 2023 Dec; 66(12):2250-2260. PubMed ID: 37725107
[TBL] [Abstract][Full Text] [Related]
2. The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.
Denniston AK; Chakravarthy U; Zhu H; Lee AY; Crabb DP; Tufail A; Bailey C; Akerele T; Al-Husainy S; Brand C; Downey L; Fitt A; Khan R; Kumar V; Lobo A; Mahmood S; Mandal K; Mckibbin M; Menon G; Natha S; Ong JM; Tsaloumas MD; Varma A; Wilkinson E; Johnston RL; Egan CA;
Br J Ophthalmol; 2017 Dec; 101(12):1673-1678. PubMed ID: 28487377
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
Virgili G; Menchini F; Murro V; Peluso E; Rosa F; Casazza G
Cochrane Database Syst Rev; 2011 Jul; (7):CD008081. PubMed ID: 21735421
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy laser photocoagulation for diabetic macular oedema.
Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
[TBL] [Abstract][Full Text] [Related]
5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
[TBL] [Abstract][Full Text] [Related]
7. Study of visual acuity and contrast sensitivity in diabetic patients with and without non-proliferative diabetic retinopathy.
Lupión Durán T; García-Ben A; Rodríguez Méndez V; Gálvez Alcázar L; García-Ben E; García-Campos JM
Int Ophthalmol; 2021 Nov; 41(11):3587-3592. PubMed ID: 34176010
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol.
Bascaran C; Mwangi N; D'Esposito F; Cleland C; Gordon I; Ulloa JAL; Maswadi R; Mdala S; Ramke J; Evans JR; Burton M
Syst Rev; 2021 Jan; 10(1):27. PubMed ID: 33446272
[TBL] [Abstract][Full Text] [Related]
9. Proportion of people with diabetic retinopathy and macular oedema varies by ethnicity in a tertiary retinal clinic in Australia: findings from the Liverpool Eye and Diabetes Study (LEADS).
Liew G; Tsang T; Marshall B; Saw M; Khachigian LM; Ong S; Ho IV; Wong V
BMJ Open; 2023 Feb; 13(2):e055404. PubMed ID: 36813495
[TBL] [Abstract][Full Text] [Related]
10. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
11. Diabetic macular oedema and visual loss: relationship to location, severity and duration.
Gardner TW; Larsen M; Girach A; Zhi X;
Acta Ophthalmol; 2009 Nov; 87(7):709-13. PubMed ID: 19817721
[TBL] [Abstract][Full Text] [Related]
12. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
[TBL] [Abstract][Full Text] [Related]
13. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.
Hsieh YT; Hsieh MC
Clin Exp Ophthalmol; 2020 May; 48(4):470-476. PubMed ID: 32065699
[TBL] [Abstract][Full Text] [Related]
14. Deep learning-based automated detection for diabetic retinopathy and diabetic macular oedema in retinal fundus photographs.
Li F; Wang Y; Xu T; Dong L; Yan L; Jiang M; Zhang X; Jiang H; Wu Z; Zou H
Eye (Lond); 2022 Jul; 36(7):1433-1441. PubMed ID: 34211137
[TBL] [Abstract][Full Text] [Related]
15. Optical Coherence Tomography Biomarkers of the Outer Blood-Retina Barrier in Patients with Diabetic Macular Oedema.
Damian I; Nicoara SD
J Diabetes Res; 2020; 2020():8880586. PubMed ID: 33110922
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography in the management of diabetic macular oedema.
Szeto SK; Lai TY; Vujosevic S; Sun JK; Sadda SR; Tan G; Sivaprasad S; Wong TY; Cheung CY
Prog Retin Eye Res; 2024 Jan; 98():101220. PubMed ID: 37944588
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Evans JR
Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
[TBL] [Abstract][Full Text] [Related]
18. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema.
Soliman W; Hasler P; Sander B; Larsen M
Acta Ophthalmol; 2012 May; 90(3):248-53. PubMed ID: 20809906
[TBL] [Abstract][Full Text] [Related]
19. Topical treatment of diabetic retinopathy: a systematic review.
Thagaard MS; Vergmann AS; Grauslund J
Acta Ophthalmol; 2022 Mar; 100(2):136-147. PubMed ID: 34096180
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for diabetic retinopathy in a cross-sectional population-based study from rural southern China: Dongguan Eye Study.
Cui Y; Zhang M; Zhang L; Zhang L; Kuang J; Zhang G; Liu Q; Guo H; Meng Q
BMJ Open; 2019 Sep; 9(9):e023586. PubMed ID: 31530585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
